Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Cash from Operations (2016 - 2025)

Bio Key International's Cash from Operations history spans 16 years, with the latest figure at 1122764.0 for Q3 2025.

  • For Q3 2025, Cash from Operations rose 12.01% year-over-year to 1122764.0; the TTM value through Sep 2025 reached 3352652.0, up 14.71%, while the annual FY2024 figure was 2914072.0, 23.18% up from the prior year.
  • Cash from Operations for Q3 2025 was 1122764.0 at Bio Key International, down from 880012.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 297084.0 in Q1 2024 and bottomed at 3198559.0 in Q1 2021.
  • The 5-year median for Cash from Operations is 1420617.0 (2024), against an average of 1302793.58.
  • The largest YoY upside for Cash from Operations was 115.4% in 2024 against a maximum downside of 753.83% in 2024.
  • A 5-year view of Cash from Operations shows it stood at 1870306.0 in 2021, then fell by 1.62% to 1900631.0 in 2022, then increased by 19.42% to 1531534.0 in 2023, then soared by 66.4% to 514564.0 in 2024, then tumbled by 118.2% to 1122764.0 in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Cash from Operations are 1122764.0 (Q3 2025), 880012.0 (Q2 2025), and 835312.0 (Q1 2025).